» Articles » PMID: 28939770

Myristoylation of Src Kinase Mediates Src-induced and High-fat Diet-accelerated Prostate Tumor Progression in Mice

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 2017 Sep 24
PMID 28939770
Citations 26
Authors
Affiliations
Soon will be listed here.
Abstract

Exogenous fatty acids provide substrates for energy production and biogenesis of the cytoplasmic membrane, but they also enhance cellular signaling during cancer cell proliferation. However, it remains controversial whether dietary fatty acids are correlated with tumor progression. In this study, we demonstrate that increased Src kinase activity is associated with high-fat diet-accelerated progression of prostate tumors and that Src kinases mediate this pathological process. Moreover, in the prostate regeneration assay, host SCID mice carrying Src(Y529F)-transduced regeneration tissues were fed a low-fat diet or a high-fat diet and treated with vehicle or dasatinib. The high-fat diet not only accelerated Src-induced prostate tumorigenesis in mice but also compromised the inhibitory effect of the anticancer drug dasatinib on Src kinase oncogenic potential We further show that myristoylation of Src kinase is essential to facilitate Src-induced and high-fat diet-accelerated tumor progression. Mechanistically, metabolism of exogenous myristic acid increased the biosynthesis of myristoyl CoA and myristoylated Src and promoted Src kinase-mediated oncogenic signaling in human cells. Of the fatty acids tested, only exogenous myristic acid contributed to increased intracellular myristoyl CoA levels. Our results suggest that targeting Src kinase myristoylation, which is required for Src kinase association at the cellular membrane, blocks dietary fat-accelerated tumorigenesis Our findings uncover the molecular basis of how the metabolism of myristic acid stimulates high-fat diet-mediated prostate tumor progression.

Citing Articles

Extracellular Vesicles: The Next Generation of Biomarkers and Treatment for Central Nervous System Diseases.

Zanirati G, Dos Santos P, Alcara A, Bruzzo F, Ghilardi I, Wietholter V Int J Mol Sci. 2024; 25(13).

PMID: 39000479 PMC: 11242541. DOI: 10.3390/ijms25137371.


Sophoridine Counteracts Obesity via Src-Mediated Inhibition of VEGFR Expression and PI3K/AKT Phosphorylation.

Sun J, Wang X, He Y, Tian X, Yuan T, Yang G Int J Mol Sci. 2024; 25(2).

PMID: 38279206 PMC: 10816114. DOI: 10.3390/ijms25021206.


Location, location, location: Protein kinase nanoclustering for optimised signalling output.

Gormal R, Martinez-Marmol R, Brooks A, Meunier F Elife. 2024; 13.

PMID: 38206309 PMC: 10783869. DOI: 10.7554/eLife.93902.


Inhibition of N-myristoyltransferase activity promotes androgen receptor degradation in prostate cancer.

Alsaidan O, Onobun E, Ye C, Lou L, Beharry Z, Xie Z Prostate. 2023; 84(3):254-268.

PMID: 37905842 PMC: 10872856. DOI: 10.1002/pros.24645.


Src family kinases engage differential pathways for encapsulation into extracellular vesicles.

Ye C, Gosser C, Runyon E, Zha J, Cai J, Beharry Z J Extracell Biol. 2023; 2(6).

PMID: 37588411 PMC: 10426749. DOI: 10.1002/jex2.96.


References
1.
Xin L, Ide H, Kim Y, Dubey P, Witte O . In vivo regeneration of murine prostate from dissociated cell populations of postnatal epithelia and urogenital sinus mesenchyme. Proc Natl Acad Sci U S A. 2003; 100 Suppl 1:11896-903. PMC: 304104. DOI: 10.1073/pnas.1734139100. View

2.
Warburg O . On the origin of cancer cells. Science. 1956; 123(3191):309-14. DOI: 10.1126/science.123.3191.309. View

3.
Strom S, Yamamura Y, Forman M, Pettaway C, Barrera S, DiGiovanni J . Saturated fat intake predicts biochemical failure after prostatectomy. Int J Cancer. 2008; 122(11):2581-5. DOI: 10.1002/ijc.23414. View

4.
Cowan-Jacob S, Fendrich G, Manley P, Jahnke W, Fabbro D, Liebetanz J . The crystal structure of a c-Src complex in an active conformation suggests possible steps in c-Src activation. Structure. 2005; 13(6):861-71. DOI: 10.1016/j.str.2005.03.012. View

5.
Cai H, Smith D, Memarzadeh S, Lowell C, Cooper J, Witte O . Differential transformation capacity of Src family kinases during the initiation of prostate cancer. Proc Natl Acad Sci U S A. 2011; 108(16):6579-84. PMC: 3080985. DOI: 10.1073/pnas.1103904108. View